Skip to main content
. 2024 May 21;12:1405770. doi: 10.3389/fpubh.2024.1405770

Table 1.

Subgroup analysis of self-management in patients with type 2 diabetes with telemedicine intervention.

Subgroup HbA1c SBP DBP
Study SMD [95%CI] p-value I 2 Study SMD [95%CI] p-value I 2 Study SMD [95%CI] p-value I 2
Total 20 −0.33 [−0.54, −0.12] 0.002 76% 6 −0.46 [−0.85, −0.06] 0.02 81% 6 −0.39 [−0.68, −0.11] 0.007 64%
Telemedicine
APP 9 −0.43 [−0.75, −0.10] 0.001 83% 4 −0.72 [−0.92, −0.51] <0.00001 44% 4 −0.54 [−0.74, −0.34] <0.00001 0
APP + Telephone 4 −0.46 [−0.86, −0.05] 0.003 17% 0 0
Telephone 2 −0.45 [−0.75, −0.15] 0.003 0 0 0
SMS 2 −0.14 [−0.42, 0.14] 0.33 0 0 0
Sensor equipment 3 −0.12 [−0.74, 0.49] 0.7 80% 2 0.02 [−0.22, 0.26] 0.88 3% 2 −0.17 [−0.77, 0.43] 0.57 62%
Duration
≥6 months 10 −0.34 [−0.67, −0.01] 0.04 88% 4 −0.47 [−1.00, 0.07] 0.09 89% 4 −0.34 [−0.71, 0.02] 0.07 76%
<6 months 10 −0.34 [−0.51, −0.16] 0.0002 0% 2 −0.44 [−0.86, −0.02] 0.04 0 2 −0.55 [−0.97, −0.13] 0.01 0
Region
Asia 10 −0.47 [−0.73, −0.22] 0.0003 73% 3 −0.80 [−1.02, −0.57] <0.00001 0 3 −0.58 [−0.80, −0.36] <0.00001 0
America 6 0.26 [0.06, 0.47] 0.01 17% 2 0.02 [−0.22, 0.26] 0.88 3% 2 −0.17 [−0.77, 0.43] 0.57 62%
Australia 2 −0.16 [−0.39, 0.07] 0.16 50% 0 0
Europe 1 −0.68 [−1.26, −0.10] 0.02 NA 1 −0.20 [−0.77, 0.37] 0.49 NA 1 −0.26 [−0.83, 0.31] 0.37 NA
Africa 1 −0.63 [−1.15, −0.11] 0.02 NA 0 0
Mean age
≥60 7 −0.33 [−1.01, 0.35] 0.34 90% 4 −0.47 [−1.00, 0.07] 0.09 89% 4 −0.34 [−0.71, 0.02] 0.07 76%
<60 13 −0.24 [−0.36, −0.13] 0.0001 33% 2 −0.44 [−0.86, −0.02] 0.04 0 2 −0.55 [−0.97, −0.13] 0.01 0

HbA1c, glycosylated hemoglobin; SBP, systolic blood pressure; DBP, diastolic blood pressure; SMD, standardized mean difference; CI, confidence interval.